Nucleotide

Canis lupus familiaris ADP ribosylation factor 1 pseudogene (LOC611567) on chromosome 10

Select item 19735040702.

794 bp linear DNA

Accession:: NG_030382.3
GI:: 1973504070

Select item 9272620403.

Chain A, 7S RNA

299 bp linear other

Accession:: 4UE5_A
GI:: 927262040

PubMed Taxonomy

Canis lupus familiaris keratin 3 (KRT3), mRNA

Select item 27279316204.

2,326 bp linear mRNA

Accession:: NM_001430140.1
GI:: 2727931620

Canis lupus familiaris aristaless related homeobox (ARX), mRNA

Select item 27279316185.

2,899 bp linear mRNA

Accession:: NM_001114666.2
GI:: 2727931618

Canis lupus familiaris ADP ribosylation factor 1 (ARF1), mRNA

Select item 27279313856.

1,828 bp linear mRNA

Accession:: NM_001251927.3
GI:: 2727931385

Canis lupus familiaris keratin 2 (KRT2), mRNA

Select item 27279313147.

2,450 bp linear mRNA

Accession:: NM_001003386.3
GI:: 2727931314

Canis lupus familiaris myocyte enhancer factor 2B (MEF2B), mRNA

Select item 27279308698.

1,368 bp linear mRNA

Accession:: NM_001205203.2
GI:: 2727930869

Canis lupus familiaris bestrophin 1 (BEST1), mRNA

Select item 1482374339.

2,209 bp linear mRNA

Accession:: NM_001097545.1
GI:: 148237433

Canis lupus familiaris tight junction protein 1 (TJP1), mRNA

Select item 5574180210.

6,805 bp linear mRNA

Accession:: NM_001003140.1
GI:: 55741802

Canis lupus familiaris fibroblast growth factor 7 (FGF7), mRNA

Select item 5097902111.

686 bp linear mRNA

Accession:: NM_001003237.1
GI:: 50979021

WO 2024005123-A/7: PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER

Select item 272201944212.

2,281 bp linear DNA

Accession:: PA643859.1
GI:: 2722019442

WO 2024005123-A/6: PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER

Select item 272201944113.

3,306 bp linear DNA

Accession:: PA643858.1
GI:: 2722019441

WO 2024005123-A/5: PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER

Select item 272201944014.

4,939 bp linear DNA

Accession:: PA643857.1
GI:: 2722019440

WO 2024005123-A/4: PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER

Select item 272201943915.

4,154 bp linear DNA

Accession:: PA643856.1
GI:: 2722019439

WO 2024005123-A/3: PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER

Select item 272201943816.

1,605 bp linear DNA

Accession:: PA643855.1
GI:: 2722019438

Canis lupus familiaris c-kit oncogenic gene, exons 10 and 11 and partial cds

Select item 255240578317.

169 bp linear DNA

Accession:: OR168075.1
GI:: 2552405783

Canis lupus familiaris c-kit gene, exons 10 and 11 and partial cds

Select item 255240578118.

210 bp linear DNA

Accession:: OR168074.1
GI:: 2552405781

Canis lupus familiaris isolate CF41.Mg nuclear protein 1 (NUPR1) mRNA, partial cds

Select item 271619955619.

186 bp linear mRNA

Accession:: PP623653.1
GI:: 2716199556

Canis lupus familiaris isolate CMT_U27 nuclear protein 1 (NUPR1) mRNA, partial cds

Select item 271619955420.

186 bp linear mRNA

Accession:: PP623652.1
GI:: 2716199554